Literature DB >> 16301866

Association between screening family medical history in general medical care and lower burden of cancer worry among women with a close family history of breast cancer.

Robert Gramling1, David Anthony, Jan Lowery, Lori Ballinger, Deb Ma, Rana Habbal, Nancy Leighton, Deborah Bowen.   

Abstract

PURPOSE: Soliciting family medical history (FMH) is the initial step in the process of screening for heritable cancer risk in medical care. We investigate whether recent solicitation of FMH in general medical care is associated with cancer worry among a sample of women having a first-degree relative with a breast cancer diagnosis.
METHODS: Surveys were mailed to women registered with the Cancer Genetics Network having a first-degree relative with a breast cancer diagnosis and a regular source of medical care. The independent measure consisted of two items for solicitation of FMH based on validated measures of clinical interactions with one's physician; the dependent measure was a novel measure of cancer worry based on validated patient-centered measure of distress; and the secondary measures were 6-point scales for perceived likelihood of developing breast cancer and perceived severity of breast cancer as a health outcome.
RESULTS: A total of 353 women responded and met eligibility criteria (76.4% minimum response rate). One fifth reported no cancer worry during the past 4 weeks. After adjustment for age, education, pedigree features, and clustering within families, recent FMH solicitation was associated with lower odds of cancer worry (odds ratio = 0.58; 95% confidence interval = 0.51-0.70). FMH solicitation was associated with lower perceptions of the severity of developing breast cancer but not with the perception of cancer likelihood.
CONCLUSIONS: Our data do not support the hypothesis that FMH solicitation in general medical practice causes cancer worry. In fact, we observed a protective association possibly explained by influences on perceptions of breast cancer severity. Prospective research among less select populations is necessary.

Entities:  

Mesh:

Year:  2005        PMID: 16301866     DOI: 10.1097/01.gim.0000187123.76699.e9

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  7 in total

1.  Genetic cancer risk assessment in general practice: systematic review of tools available, clinician attitudes, and patient outcomes.

Authors:  Flore Laforest; Pia Kirkegaard; Baljinder Mann; Adrian Edwards
Journal:  Br J Gen Pract       Date:  2018-12-03       Impact factor: 5.386

2.  Building a successful research enterprise in family medicine: the Brown experience.

Authors:  Sean P David; Charles B Eaton; Larry Culpepper; Roberta E Goldman; Laura K Lavallee; Emma M Simmons
Journal:  Med Health R I       Date:  2006-08

3.  Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment.

Authors:  Paul Bennett; Clare Wilkinson; Jim Turner; Rhiannon Tudor Edwards; Barbara France; Gethin Griffith; Gethin Griffin; Jonathon Gray
Journal:  Fam Cancer       Date:  2008-11-15       Impact factor: 2.375

4.  Concerns about inherited risk of breast cancer prior to diagnosis in Japanese patients with breast complaints.

Authors:  Noriko Ando; Yumi Iwamitsu; Masaru Kuranami; Shigemi Okazaki; Kenji Yamamoto; Masahiko Watanabe; Hitoshi Miyaoka
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

5.  Genetic risk, perceived risk, and cancer worry in daughters of breast cancer patients.

Authors:  John M Quillin; Joann N Bodurtha; Donna McClish; Diane Baer Wilson
Journal:  J Genet Couns       Date:  2010-12-04       Impact factor: 2.537

6.  Missed opportunities: family history and behavioral risk factors in breast cancer risk assessment among a multiethnic group of women.

Authors:  Leah S Karliner; Anna Napoles-Springer; Karla Kerlikowske; Jennifer S Haas; Steven E Gregorich; Celia Patricia Kaplan
Journal:  J Gen Intern Med       Date:  2007-03       Impact factor: 5.128

7.  Recruiting diverse patients to a breast cancer risk communication trial--waiting rooms can improve access.

Authors:  Joann N Bodurtha; John M Quillin; Kelly A Tracy; Joseph Borzelleca; Donna McClish; Diane Baer Wilson; Resa M Jones; Julie Quillin; Deborah Bowen
Journal:  J Natl Med Assoc       Date:  2007-08       Impact factor: 1.798

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.